Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : Efficacy and safety of adding evogliptin versus sitagliptin for metformin-treated patients with type 2 diabetes: A 24-week randomized, controlled trial with open label extension - Hong_2017_Diabetes.Obes.Metab_19_654 |
| Author(s) : Hong SM , Park CY , Hwang DM , Han KA , Lee CB , Chung CH , Yoon KH , Mok JO , Park KS , Park SW |
| Ref : Diabetes Obes Metab , 19 :654 , 2017 |
| Abstract : Hong_2017_Diabetes.Obes.Metab_19_654 |
| ESTHER : Hong_2017_Diabetes.Obes.Metab_19_654 |
| PubMedSearch : Hong_2017_Diabetes.Obes.Metab_19_654 |
| PubMedID: 28058750 |
| Title : Pharmacological profiles of gemigliptin (LC15-0444), a novel dipeptidyl peptidase-4 inhibitor, in vitro and in vivo - Kim_2016_Eur.J.Pharmacol_788_54 |
| Author(s) : Kim SH , Jung E , Yoon MK , Kwon OH , Hwang DM , Kim DW , Kim J , Lee SM , Yim HJ |
| Ref : European Journal of Pharmacology , 788 :54 , 2016 |
| Abstract : Kim_2016_Eur.J.Pharmacol_788_54 |
| ESTHER : Kim_2016_Eur.J.Pharmacol_788_54 |
| PubMedSearch : Kim_2016_Eur.J.Pharmacol_788_54 |
| PubMedID: 27298192 |
| Title : Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study - Lim_2008_Clin.Ther_30_1817 |
| Author(s) : Lim KS , Kim JR , Choi YJ , Shin KH , Kim KP , Hong JH , Cho JY , Shin HS , Yu KS , Shin SG , Kwon OH , Hwang DM , Kim JA , Jang IJ |
| Ref : Clin Ther , 30 :1817 , 2008 |
| Abstract : Lim_2008_Clin.Ther_30_1817 |
| ESTHER : Lim_2008_Clin.Ther_30_1817 |
| PubMedSearch : Lim_2008_Clin.Ther_30_1817 |
| PubMedID: 19014837 |